drugset / Trial / NCT07000305
A Study of Cetuximabβ Combined With Envolimab and mFOLFOX6 in Subjects With Advanced Colorectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
A study of Cetuximabβ combined with Envolimab and mFOLFOX6 in Subjects with Advanced Colorectal Cancer
Timeline
- Start
- 2025-05-20
- Primary completion
- 2027-05-20
- Completion
- 2028-05-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cetuximab β | Monoclonal antibody | 500 mg/m2 | Intravenous |
| Subject | Envolimab | Unknown | 200 mg | Subcutaneous |